Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ATR Stock Forecast 2026-2027
$124.71
Current Price
$8.22B
Market Cap
Buy 5
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to ATR Price Targets
+76.4%
To High Target of $220.00
+20.3%
To Median Target of $150.00
+6.6%
To Low Target of $133.00
ATR Price Momentum
+0.7%
1 Week Change
+1.7%
1 Month Change
-20.1%
1 Year Change
+2.3%
Year-to-Date Change
-24.1%
From 52W High of $164.28
+20.8%
From 52W Low of $103.23
📊 TOP ANALYST CALLS
Did ATR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if AptarGroup is one of their latest high-conviction picks.
Latest ATR Stock Price Targets & Analyst Predictions
Based on our analysis of 14 Wall Street analysts, ATR has a bullish consensus with a median price target of $150.00 (ranging from $133.00 to $220.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $124.71, the median forecast implies a 20.3% upside. This outlook is supported by 5 Buy, 3 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Paul Knight at Keybanc, projecting a 76.4% upside. Conversely, the most conservative target is provided by Gabe Hajde at Wells Fargo, suggesting a 6.6% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ATR Analyst Ratings
5
Buy
3
Hold
0
Sell
ATR Price Target Range
Low
$133.00
Average
$150.00
High
$220.00
Current: $124.71
Latest ATR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ATR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 6, 2026 | Wells Fargo | Gabe Hajde | Equal-Weight | Downgrade | $133.00 |
| Nov 3, 2025 | Wells Fargo | Gabe Hajde | Overweight | Maintains | $133.00 |
| Nov 3, 2025 | Baird | Ghansham Panjabi | Outperform | Maintains | $145.00 |
| Sep 10, 2025 | Wells Fargo | Gabe Hajde | Overweight | Maintains | $152.00 |
| Sep 4, 2025 | Keybanc | Paul Knight | Overweight | Initiates | $220.00 |
| Aug 4, 2025 | Wells Fargo | Gabe Hajde | Overweight | Maintains | $153.00 |
| Aug 4, 2025 | Raymond James | Matt Roberts | Outperform | Maintains | $172.00 |
| Jul 18, 2025 | Wells Fargo | Gabe Hajde | Overweight | Maintains | $173.00 |
| Jul 15, 2025 | Raymond James | Matt Roberts | Outperform | Maintains | $182.00 |
| May 6, 2025 | Wells Fargo | Gabe Hajde | Overweight | Maintains | $170.00 |
| Apr 22, 2025 | Raymond James | Matt Roberts | Outperform | Maintains | $175.00 |
| Feb 10, 2025 | Raymond James | Matt Roberts | Outperform | Reiterates | $190.00 |
| Feb 10, 2025 | Baird | Ghansham Panjabi | Outperform | Maintains | $160.00 |
| Feb 10, 2025 | Wells Fargo | Gabe Hajde | Overweight | Maintains | $170.00 |
| Jan 7, 2025 | Raymond James | Matt Roberts | Outperform | Initiates | $200.00 |
| Jan 6, 2025 | Wells Fargo | Gabe Hajde | Overweight | Maintains | $180.00 |
| Oct 28, 2024 | Baird | Ghansham Panjabi | Outperform | Maintains | $185.00 |
| Oct 15, 2024 | Wells Fargo | Gabe Hajde | Overweight | Maintains | $185.00 |
| Oct 14, 2024 | Jefferies | Daniel Rizzo | Buy | Upgrade | $215.00 |
| Jul 17, 2024 | Wells Fargo | Gabe Hajde | Overweight | Maintains | $168.00 |
AptarGroup, Inc. (ATR) Competitors
The following stocks are similar to AptarGroup based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
AptarGroup, Inc. (ATR) Financial Data
AptarGroup, Inc. has a market capitalization of $8.22B with a P/E ratio of 20.1x. The company generates $3.66B in trailing twelve-month revenue with a 11.5% profit margin.
Revenue growth is +5.7% quarter-over-quarter, while maintaining an operating margin of +15.1% and return on equity of +15.6%.
Valuation Metrics
Market Cap
$8.22B
Enterprise Value
$9.38B
P/E Ratio
20.1x
PEG Ratio
0.7x
Price/Sales
2.3x
Growth & Margins
Revenue Growth (YoY)
+5.7%
Gross Margin
+37.8%
Operating Margin
+15.1%
Net Margin
+11.5%
EPS Growth
+27.9%
Financial Health
Cash/Price Ratio
+3.2%
Current Ratio
1.2x
Debt/Equity
45.6x
ROE
+15.6%
ROA
+6.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
AptarGroup, Inc. (ATR) Business Model
About AptarGroup, Inc.
What They Do
Designs and manufactures innovative dispensing systems.
Business Model
AptarGroup generates revenue by providing customized dispensing solutions, including pumps and aerosol valves, to various consumer and industrial markets. Their focus on enhancing product accessibility and user experience while ensuring sustainability allows them to cater to clients in healthcare, personal care, food and beverage, and more.
Additional Information
With a global presence and headquarters in Crystal Lake, Illinois, AptarGroup is a significant player in the packaging industry, emphasizing sustainability and innovation. Their commitment to eco-friendly solutions positions them well in a market increasingly focused on environmental responsibility.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
13,000
CEO
Mr. Stephan B. Tanda
Country
United States
IPO Year
1993
Website
www.aptar.comAptarGroup, Inc. (ATR) Latest News & Analysis
Latest News
AptarGroup, Inc. (ATR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
4 days ago
Quick Summary
AptarGroup, Inc. (ATR) participated in the 44th Annual J.P. Morgan Healthcare Conference, providing insights into the company's strategies and performance.
Why It Matters
AptarGroup's presentation at a key healthcare conference indicates potential growth opportunities, investor interest in innovations, and may influence stock performance and market perception.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Investors should monitor ATR stock due to recent activity in the options market.
Why It Matters
ATR stock movements in the options market indicate potential volatility or sentiment shifts, which can impact stock performance and trading strategies.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Aptar has announced the dates for its 2026 quarterly conference calls, providing investors with scheduled opportunities for updates and financial insights.
Why It Matters
Aptar's announcement of 2026 quarterly conference call dates signals transparency and future communication plans, indicating ongoing investor engagement and potential insights into financial performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Aptar will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.
Why It Matters
Aptar's presentation at a major healthcare conference may signal strategic initiatives or innovations, influencing investor sentiment and stock performance in the healthcare sector.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Aptar Group's Bidose Liquid Nasal Spray System is approved for delivering CARDAMYST™ (etripamil), now FDA-approved for treating acute PSVT episodes.
Why It Matters
Aptar Group's FDA approval of the Bidose Nasal Spray for CARDAMYST enhances its product portfolio, potentially increasing revenue and market share in the pharmaceutical sector.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
AptarGroup, Inc. (NYSE: ATR) has acquired Sommaplast, a Brazilian company specializing in oral dosing pharma packaging solutions.
Why It Matters
AptarGroup's acquisition of Sommaplast expands its product offerings in the pharmaceutical packaging sector, potentially driving revenue growth and enhancing market competitiveness.
Source: Benzinga
Market Sentiment:
Positive
Frequently Asked Questions About ATR Stock
What is AptarGroup, Inc.'s (ATR) stock forecast for 2026?
Based on our analysis of 14 Wall Street analysts, AptarGroup, Inc. (ATR) has a median price target of $150.00. The highest price target is $220.00 and the lowest is $133.00.
Is ATR stock a good investment in 2026?
According to current analyst ratings, ATR has 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $124.71. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ATR stock?
Wall Street analysts predict ATR stock could reach $150.00 in the next 12 months. This represents a 20.3% increase from the current price of $124.71. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is AptarGroup, Inc.'s business model?
AptarGroup generates revenue by providing customized dispensing solutions, including pumps and aerosol valves, to various consumer and industrial markets. Their focus on enhancing product accessibility and user experience while ensuring sustainability allows them to cater to clients in healthcare, personal care, food and beverage, and more.
What is the highest forecasted price for ATR AptarGroup, Inc.?
The highest price target for ATR is $220.00 from Paul Knight at Keybanc, which represents a 76.4% increase from the current price of $124.71.
What is the lowest forecasted price for ATR AptarGroup, Inc.?
The lowest price target for ATR is $133.00 from Gabe Hajde at Wells Fargo, which represents a 6.6% increase from the current price of $124.71.
What is the overall ATR consensus from analysts for AptarGroup, Inc.?
The overall analyst consensus for ATR is bullish. Out of 14 Wall Street analysts, 5 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $150.00.
How accurate are ATR stock price projections?
Stock price projections, including those for AptarGroup, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 18, 2026 8:16 PM UTC